Jaguar Health (JAGX) Deferred Taxes (2017)
Jaguar Health's (JAGX) quarterly Deferred Taxes came in at -$990549.0 in Q4 2017.
Jaguar Health (JAGX) Deferred Taxes (2017) Analysis & Trends
Jaguar Health (JAGX) has 1 years of Deferred Taxes data on file, last reported at -$990549.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,782.24 Bn | 1,782.18 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | -859,000.00 |
| 3 | BeOne Medicines | 473.46 Bn | 468.66 Bn | 1.35 Bn | - |
| 4 | Vertex Pharmaceuticals | 123.84 Bn | 116.59 Bn | 2.59 Bn | -65.30 Mn |
| 5 | Regeneron Pharmaceuticals | 71.69 Bn | 62.94 Bn | 3.31 Bn | 96.00 Mn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.74 Bn | 49.55 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.08 Bn | 35.07 Bn | 959.66 Mn | 9.31 Mn |
| 9 | Revolution Medicines | 36.07 Bn | 36.07 Bn | - | - |
| 10 | Jaguar Health | 520,945.88 | -9.54 Mn | 19.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -990,549.00 |